Legal Representation
Attorney
Jared M. Barrett
USPTO Deadlines
Next Deadline
1374 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-02)
Due Date
May 02, 2029
Grace Period Ends
November 02, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 2, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 2, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 31, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 30, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 9, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 9, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 22, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 22, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Dec 22, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 20, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 20, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 28, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 3, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 3, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 28, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
First Use Anywhere:
Feb 17, 2023
First Use in Commerce:
Feb 17, 2023
Classification
International Classes
005